Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,729 | 7,575 | 11,446 | 16,985 | 1,630 |
| Receivables | 437 | 425 | 951 | 684 | N/A |
| TOTAL | $2,352 | $9,599 | $13,681 | $18,766 | $1,732 |
| Non-Current Assets | |||||
| PPE Net | 85 | 493 | 236 | 670 | 594 |
| Investments And Advances | 0 | 0 | 59 | 1,000 | 0 |
| Intangibles | 2,044 | 2,044 | 2,044 | 2,044 | 2,044 |
| Other Non-Current Assets | 788 | 36,996 | 6,259 | 9,045 | 8,536 |
| TOTAL | $2,917 | $39,533 | $8,598 | $12,759 | $11,174 |
| Total Assets | $5,269 | $49,132 | $22,279 | $31,525 | $12,906 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 116 |
| Accounts payable and accrued liabilities | 1,721 | 2,272 | 3,370 | 1,755 | 1,275 |
| Accrued Expenses | 1,007 | 1,893 | 3,626 | 1,249 | 1,051 |
| Other current liabilities | N/A | N/A | 363 | 247 | 0 |
| TOTAL | $2,938 | $6,573 | $7,654 | $3,677 | $3,125 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 194 |
| Deferred Revenues | 0 | 190 | 0 | N/A | N/A |
| Other Non-Current Liabilities | 630 | 39,934 | 2,518 | 2,345 | 1,928 |
| TOTAL | $630 | $40,326 | $2,518 | $2,345 | $2,122 |
| Total Liabilities | $3,568 | $46,899 | $10,172 | $6,022 | $5,247 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,485 | 361 | 342 | 192 | 5 |
| Common Shares | 257 | 27 | 26 | 13 | 25,800 |
| Retained earnings | -231,536 | -186,981 | -165,297 | -140,702 | -18,141 |
| TOTAL | $1,701 | $2,233 | $12,107 | $25,503 | $7,659 |
| Total Liabilities And Equity | $5,269 | $49,132 | $22,279 | $31,525 | $12,906 |